Indo Us Biotech Limited — Others, 12-02-2025: Copy of Newspaper Publication

Arex Industries Limited reported its unaudited financial results for the quarter and nine months ended December 31, 2024. The total income from operations stands at ₹11.12 crore, while the company has recorded a loss before tax of ₹6.66 crore, with a comprehensive loss of ₹6.6 crore for the period. The paid-up equity share capital remains at ₹69.70 crore, and earnings per share (EPS) are at ₹(9.53) for the period.

The outcomes reflect ongoing challenges in profitability, which may raise concerns among investors regarding operational efficiencies and market conditions. However, the company’s stable capital structure could position it for recovery, suggesting a positive outlook if management addresses the losses effectively.